Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma-Reference-Cited by-同舟云学术

Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma

Published:2012-08 Issue:33 Volume:287 Page:28087-28098
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Yadav Vipin,Zhang Xiaoyi,Liu Jiangang,Estrem Shawn,Li Shuyu,Gong Xue-Qian,Buchanan Sean,Henry James R.,Starling James J.,Peng Sheng-Bin

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference37 articles.

1. Global Cancer Statistics;Jemal;CA Cancer J. Clin.,2011

2. Final version of 2009 AJCC melanoma staging and classification;Balch;J. Clin. Oncol.,2009

3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance;McCubrey;Adv. Enzyme Regul.,2006

4. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

5. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

2. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16

3. Patient-derived melanoma models;Pathology - Research and Practice;2024-07

4. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

5. Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells;Cancers;2024-01-22